The Enterprise Immune System has been widely praised by the world’s leading IT research firms, including Gartner, Ovum, and 451 Research.
“Darktrace offers a fundamentally different platform that’s powering an entire cyber defense strategy with AI and machine learning.”
“Ovum sees Darktrace as a market leader that provides a strong example of leveraging artificial intelligence.”
“The incorporation of unsupervised, supervised, and deep learning into its product offering puts Darktrace well ahead of the game and makes it a compelling candidate for any enterprise’s cyber security tooling plans.”
451 Research: ‘Darktrace succeeding with a focus on the ‘good’ and the ‘not good enough’’
This report analyzes how Darktrace's use of unsupervised machine learning is positioning it as the leader in anomaly detection, and outlines how Darktrace Antigena autonomously responds to potential threats in real time.
“Darktrace is the clear leader in anomaly detection.”
“Key differentiation with respect to detection is seen in Darktrace’s ability to accurately judge gray-area anomalous activity.”
“Darktrace is well ahead of anomaly detection and behavioral analytics peers in terms of market presence.”
See our Industry Analyst Reports page for more analyst reports on Darktrace’s Enterprise Immune System.